Back to mobile site

Pfizer (PFE) Reiterates at Neutral by Cantor Fitzgerald

June 1, 2026 8:02 AM EDT Send to a Friend
Cantor Fitzgerald analyst Carter Gould reiterated a Neutral rating and $27.00 price target on Pfizer (NYSE: PFE).The analyst commented, "Saturday ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login